4
Changes in Ownership
PALISADE BIO, INC. Filed Acc 0001493152-22-023510
Chief Financial Officer bought 100,000 shares at $0.25 ($25,000)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David Chief Financial Officer | 2022-08-16 | Purchase | +100,000 | $0.25 | $25,000 | 121,896 | D: show line 1 in the form |
| Open-market purchases · 100,000 sh · avg $0.25 · $25,000 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Finley John David Chief Financial Officer | 2022-08-16 | Purchase · Series 1 Common Stock Purchase Warrant | +100,000 | 100,000 | D: show line 2 in the form | ||
| Finley John David Chief Financial Officer | 2022-08-16 | Purchase · Series 2 Common Stock Purchase Warrant | +100,000 | 100,000 | D: show line 3 in the form |
Loading xslF345X03/ownership.xml…